Lobo Kevin
SEC Form 4 insider trading activity
Lobo Kevin has filed 8 SEC Form 4 filings (10 transaction rows) across 3 companies, including GEHC, SYK, PH, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: May 26, 2026.
On the most recent filing, Lobo Kevin is listed as Director at GE HealthCare Technologies Inc. Inside the rolling window, Lobo Kevin reported 1 open-market purchase totaling $642K in GEHC and no open-market sales.
Companies traded
Other insiders at GEHC
Insider Buying
$642K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lobo Kevin made?
Lobo Kevin has filed 8 SEC Form 4 filings (10 transaction rows) across 3 companies, including GEHC, SYK, PH since 2025.
Which companies does Lobo Kevin trade?
Lobo Kevin has filed SEC Form 4 disclosures for 3 companies, including GEHC, SYK, PH.
When was Lobo Kevin's most recent SEC Form 4 filing?
Lobo Kevin's most recent SEC Form 4 filing on Tracefour is dated May 26, 2026.
What is Lobo Kevin's total buy and sell value in the current window?
Inside the rolling retention window, Lobo Kevin bought $642K and sold $0 based on SEC Form 4 filings.
What was Lobo Kevin's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 GEHC shares on 2026-05-22, worth $642K, per SEC Form 4 filings.